NantBioscience Garners $10,000,000 Seed Funding

  • Feed Type
  • Date
    6/3/2015
  • Company Name
    NantBioscience
  • Mailing Address
    9920 Jefferson Blvd. Culver City, CA 90232 USA
  • Company Description
    NantBioScience, a NantWorks company, is a biopharmaceutical company focused on the discovery of medicines designed to target the root cause of cancer growth and spread. Dr. Patrick Soon-Shiong, the creator of Abraxane® and the founder of the nano albumin-bound (nab®) technology platform, established NantBioScience in 2011.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Seed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy